TransMedics (TMDX) Non-Current Deffered Revenue (2018 - 2021)

TransMedics' Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $1.6 million for Q3 2021.

• On a quarterly basis, Non-Current Deffered Revenue changed 0.43% year-over-year to $1.6 million in Q3 2021; TTM through Sep 2021 was $1.6 million, a 0.43% change from a year earlier, with the FY2020 full-year figure at $1.6 million, up 311.05% from the prior year.
• Non-Current Deffered Revenue climbed to $1.6 million in Q3 2021 per TMDX's latest filing, from $1.5 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $1.6 million in Q3 2020 and bottomed at $389000.0 in Q4 2019.
• The 4-year median for Non-Current Deffered Revenue is $932000.0 (2020), against an average of $1.1 million.
• Across the five-year window, Non-Current Deffered Revenue tumbled 48.75% in 2019 and soared 311.05% in 2020, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $759000.0 in 2018, then tumbled by 48.75% to $389000.0 in 2019, then surged by 311.05% to $1.6 million in 2020, then increased by 1.06% to $1.6 million in 2021.
• Per Business Quant, the three latest TMDX Non-Current Deffered Revenue figures stand at $1.6 million (Q3 2021), $1.5 million (Q2 2021), and $1.6 million (Q1 2021).